lamivudine has been researched along with Lymphoma, B-Cell in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 6 (54.55) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adinolfi, LE; Boemio, A; Capoluongo, N; Coppola, N; D'Amore, C; Esposito, M; Guastafierro, S; Macera, M; Marrone, A; Mastrullo, L; Minichini, C; Onorato, L; Pisaturo, M; Rinaldi, L; Sagnelli, E; Siniscalchi, I | 1 |
| Allison, ME; Dillon, R; Hirschfield, GM; Rege, KP | 1 |
| Chen, CH; Hu, TH; Kuo, CY; Lee, CM; Ma, MC; Pei, SN; Wang, MC | 1 |
| Fukai, K; Ise, M; Kojima, H; Kumagai, K; Mimura, N; Sakai, C; Takagi, T; Tsujimura, H; Yokosuka, O | 1 |
| Arcaini, L; Bruno, R; Lucioni, M; Merli, M; Paulli, M; Rattotti, S; Riboni, R; Vercelli, A | 1 |
| Fan, L; Fang, C; Li, JY; Wang, L; Wang, YH; Xu, J; Xu, W; Zhang, R | 1 |
| Chao, TY; Dai, MS; Kao, WY; Liu, TM; Shyu, RY | 1 |
| Erb, SR; Ho, JK; Hoskins, PJ; Law, JK; Steinbrecher, UP; Yoshida, EM | 1 |
| Hayashi, T; Iyama, S; Kato, J; Kawano, Y; Kobune, M; Matsunaga, T; Miyanishi, K; Niitsu, Y; Okuda, T; Ono, K; Sagawa, T; Sato, T; Sato, Y; Takada, K; Takimoto, R | 1 |
| Chambers, S; Chapman, BA; Clark, FL; Drummond, MW; Patton, WN | 1 |
| Fujii, S; Fujiwara, T; Fukuda, S; Sezaki, T; Sunami, K; Yoshida, C | 1 |
11 other study(ies) available for lamivudine and Lymphoma, B-Cell
| Article | Year |
|---|---|
Eighteen-month lamivudine prophylaxis on preventing occult hepatitis B virus infection reactivation in patients with haematological malignancies receiving immunosuppression therapy.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antiviral Agents; DNA, Viral; Female; Hematologic Neoplasms; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunosuppressive Agents; Lamivudine; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, B-Cell; Male; Middle Aged; Virus Activation; Young Adult | 2018 |
Fatal reactivation of hepatitis B after chemotherapy for lymphoma.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cyclophosphamide; Doxorubicin; Fatal Outcome; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Failure, Acute; Lymphoma, B-Cell; Prednisone; Rituximab; Vincristine; Virus Activation | 2008 |
Reactivation of hepatitis B virus following rituximab-based regimens: a serious complication in both HBsAg-positive and HBsAg-negative patients.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Incidence; Lamivudine; Lymphoma, B-Cell; Male; Middle Aged; Premedication; Retrospective Studies; Rituximab; Virus Activation | 2010 |
[Hepatitis B virus reactivation after cessation of prophylactic lamivudine therapy in B-cell lymphoma patients treated with rituximab combined CHOP therapy].
Topics: Adult; Aged; Anti-HIV Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carrier State; Cyclophosphamide; Doxorubicin; Female; Hepatitis B; Hepatitis B virus; Humans; Immunocompromised Host; Lamivudine; Lymphoma, B-Cell; Male; Middle Aged; Prednisolone; Rituximab; Vincristine; Virus Activation | 2009 |
Regression of indolent B-cell lymphoma after Lamivudine prophylaxis of hepatitis B virus infection.
Topics: Antiviral Agents; Asymptomatic Diseases; Bone Marrow; Carrier State; Cell Transformation, Viral; Disease Progression; Female; Genes, bcl-2; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Lymphoma, B-Cell; Lymphoma, Follicular; Middle Aged; Neoplasm, Residual; Remission Induction; Splenic Neoplasms | 2011 |
Efficacy of prophylactic lamivudine to prevent hepatitis B virus reactivation in B-cell lymphoma treated with rituximab-containing chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Female; Hepatitis B; Hepatitis B Surface Antigens; Humans; Lamivudine; Liver Function Tests; Lymphoma, B-Cell; Male; Middle Aged; Retrospective Studies; Reverse Transcriptase Inhibitors; Rituximab; Virus Activation | 2013 |
Delayed hepatitis B virus reactivation after cessation of preemptive lamivudine in lymphoma patients treated with rituximab plus CHOP.
Topics: Adult; Alanine Transaminase; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bilirubin; Cyclophosphamide; DNA-Directed DNA Polymerase; DNA, Viral; Doxorubicin; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Lymphoma, B-Cell; Male; Mutation; Prednisone; Recurrence; Reverse Transcriptase Inhibitors; Rituximab; Sequence Analysis, DNA; Vincristine; Virus Activation | 2004 |
Fatal reactivation of hepatitis B post-chemotherapy for lymphoma in a hepatitis B surface antigen-negative, hepatitis B core antibody-positive patient: potential implications for future prophylaxis recommendations.
Topics: Aged; Anti-HIV Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fatal Outcome; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Failure; Lymphoma, B-Cell; Male; Prednisone; Rituximab; Vincristine; Virus Activation | 2005 |
[Reactivation of hepatitis B virus due to rituximab plus CHOP after preemptive lamivudine administration in a patient with diffuse large B-cell lymphoma].
Topics: Anti-HIV Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; DNA, Viral; Doxorubicin; Female; Hepatitis B; Hepatitis B virus; Humans; Interferon-beta; Lamivudine; Lymphoma, B-Cell; Middle Aged; Prednisone; Rituximab; Vincristine; Virus Activation | 2007 |
Successful treatment with lamivudine for fulminant reactivated hepatitis B infection following intensive therapy for high-grade non-Hodgkin's lymphoma.
Topics: Adult; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Carrier State; Fatal Outcome; Hepatitis B; Humans; Lamivudine; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Recurrence | 1998 |
[Prevention of hepatitis B flare-up using lamivudine in a patient with non-Hodgkin's lymphoma after allogeneic bone marrow transplantation].
Topics: Adult; Bone Marrow Transplantation; Hepatitis B; Humans; Lamivudine; Lymphoma, B-Cell; Male; Postoperative Period; Reverse Transcriptase Inhibitors; Transplantation, Homologous | 2000 |